Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
NEW YORK, June 23, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
This report studies the current scenario as well as the future market potential for continuous glucose monitoring systems (CGMS) globally. The market for these CGMS has been segmented by major devices/brands, namely, Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo System and others. The market for these systems has been extensively analyzed on the basis of factors such as their commercial launch, sales revenue, geographic presence, usage and technological developments. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2013 to 2019.
Geographically, the continuous glucose monitoring market has been classified into four segments namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the report comprises qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter's five force analysis and market attractiveness analysis.
The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global continuous glucose monitoring market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market shares. The report concludes with the profiles of major players in the global continuous glucose monitoring market such as Medtronic, Inc., Dexcom, Inc., Abbott Laboratories, Inc., Bayer AG, Nova Biomedical Corporation, Senseonics, Incorporated, GlySens, Incorporated and Insulet Corporation.
The global continuous glucose monitoring market is segmented as follows:
Continuous Glucose Monitoring Market, by Device/Brand
Guardian Real Time CGM System
FreeStyle Navigator
Dexcom Seven Plus CGM System
Dexcom G4 Platinum
MiniMed Paradigm Revel/Veo System
Others
Continuous Glucose Monitoring Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.3.2 Assumptions
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
2.2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rise in diabetic population globally
3.2.2 Rise in demand for point of care testing (POCT)
3.3 Market Restraints
3.3.1 Unfavourable reimbursement policies
3.3.2 Calibration issues
3.4 Market Opportunities
3.4.1 Development of continuous glucose monitoring devices based on non-invasive techniques
3.5 Porter's Five Forces Analysis for the Global Continuous Glucose Monitoring Market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of substitutes
3.5.4 Threat of new entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography
Chapter 4 Continuous Glucose Monitoring (CGM) Market, by Device/Brand, 2011 – 2019 (USD Million)
4.1 Overview
4.1.1 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 – 2019 (USD Million)
4.2 Guardian Real Time CGM System
4.2.1 Global Guardian Real Time CGM System Market, 2011 – 2019 (USD Million)
4.3 FreeStyle Navigator
4.3.1 Global FreeStyle Navigator Market, 2011 – 2019 (USD Million)
4.4 Dexcom Seven Plus CGM System
4.4.1 Global Dexcom Seven Plus CGM System Market, 2011 – 2019 (USD Million)
4.5 Dexcom G4 Platinum
4.5.1 Global Dexcom G4 Platinum Market, 2011 – 2019 (USD Million)
4.6 MiniMed Paradigm Revel/Veo System
4.6.1 Global MiniMed Paradigm Revel/Veo System Market, 2011 – 2019 (USD Million)
4.7 Others
4.7.1 Global Other CGM Systems Market, 2011 – 2019 (USD Million)
Chapter 5 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million)
5.1 Overview
5.1.1 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million)
5.1.2 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.3 Europe
5.3.1 Europe Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 Rest of the World (RoW) Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
Chapter 6 Competitive Landscape
6.1 Market Share Analysis by Key Players: Global Continuous Glucose Monitoring Market
6.1.1 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)
Chapter 7 Recommendations
7.1 Focus on emerging economies of Asia-Pacific, Latin America, Middle East and Africa
7.2 Investing in research and development of technologically advanced products with added benefits
7.3 Emphasis on price control
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Bayer AG
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Dexcom, Inc.
8.3.1 Company overview
8.3.2 Financial overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 GlySens Incorporated
8.4.1 Company overview
8.4.2 Product Portfolio
8.4.3 Business Strategies
8.5 Insulet Corporation
8.5.1 Company overview
8.5.2 Financial overview
8.5.3 Product portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Medtronic, Inc.
8.6.1 Business Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Development
8.7 Nova Biomedical Corporation
8.7.1 Company overview
8.7.2 Product portfolio
8.7.3 Business Strategies
8.7.4 Recent Developments
8.8 Senseonics, Incorporated
8.8.1 Company overview
8.8.2 Product portfolio
8.8.3 Business Strategies
8.8.4 Recent Developments
List of Figures
FIG. 1 Continuous Glucose Monitoring: Market Segmentation
FIG. 2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)
FIG. 3 Porter's Five Force Analysis: Global Continuous Glucose Monitoring Market
FIG. 4 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography
FIG. 5 Global Guardian Real Time CGM System Market, 2011 – 2019 (USD Million)
FIG. 6 Global FreeStyle Navigator Market, 2011 – 2019 (USD Million)
FIG. 7 Global Dexcom Seven Plus CGM System Market, 2011 – 2019 (USD Million)
FIG. 8 Global Dexcom G4 Platinum Market, 2011 – 2019 (USD Million)
FIG. 9 Global MiniMed Paradigm Revel/Veo System Market, 2011 – 2019 (USD Million)
FIG. 10 Global Other CGM Systems Market, 2011 – 2019 (USD Million)
FIG. 11 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
FIG. 12 North America Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Europe Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 RoW Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)
FIG. 17 Annual Revenue: Abbott Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 18 Annual Revenue: Bayer AG., 2010 – 2012 (USD Million)
FIG. 19 Annual Revenue: Dexcom, Inc., 2010 – 2012 (USD Million)
FIG. 20 Annual Revenue: Insulet Corporation, 2010 – 2012 (USD Million)
FIG. 21 Annual Revenue: Medtronic, Inc., 2010 – 2012 (USD Million)
List of Tables
TABLE 1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
TABLE 2 Number of People with Diabetes (20-79 years), by Country/Territory, 2013 (Millions)
TABLE 3 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 – 2019 (USD Million)
TABLE 4 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 – 2019 (USD Million)
To order this report: Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
http://www.reportlinker.com/p02042915/Continuous-Glucose-Monitoring-Market-Guardian-Real-Time-FreeStyle-Navigator-Dexcom-Seven-Plus-Dexcom-G4-Platinum-MiniMed-Paradigm-Revel/Veo-CGM-Systems-and-Others---Global-Industry-Analysis-Size-Share-Growth-Trends-and-Forecast-2013---2019.html
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article